[클릭AI] Alpha Fold developers, recent drug startups, etc.

-

(Photo = Lator Labs)

■ Core developers who participated in the event of the AI ​​’Alpha Fold 2′ in Google Deep Mind established a brand new drug development startup. Attracting $ 50 million in seed investmentSuccessful. Within the investment round of Latent Labs, founded by Simon Call, Google’s chief scientist Jeff Dean and Aidan Gomez Coher were also involved. The corporate plans to design synthetic proteins that might be used for the pharmaceutical industry, cooperation, and recent drugs.

■ ENCHARGE AI, a reasoning chip, within the series B funding round Equipped with greater than $ 100 million (about 14.43 billion won)It was announced. The corporate develops an analog computing chip in memory that handles reasoning on local devices. Through this, it’s argued that AI work might be performed with energy consumption as much as 20 times lower than existing AI chips. The investment was led by Tiger Global, and Samsung Electronics participated.

■ It’s reported that the British government is considering introducing Antropic’s ‘Claude’ on the chatbot for the general public service. Antropic has a MOU with the Ministry of Science and Technology (DSIT). He announced that he’ll seek ways to enhance public services for the British people. Specifically, for this cooperation, Antroppac recently utilized the ‘Economic Index’ published. This can be a report that analyzes using chatbots of Claude users and analyzes the impact of AI on the labor market and economy.

AI Times news@aitimes.com

ASK ANA

What are your thoughts on this topic?
Let us know in the comments below.

0 0 votes
Article Rating
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments

Share this article

Recent posts

0
Would love your thoughts, please comment.x
()
x